Physician profile
Perwaiz M Meraj
NPI 1104088962
$73,940.86
in general payments reported to CMS, 2019-2025
29 companies · $20K in 2025
The $20K reported for 2025 was more than what 93% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30K · 2020: $6,712 · 2021: $8,000 · 2022: $1,078 · 2023: $4,467 · 2024: $3,901 · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,725 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,677 · Food and Beverage: $3,502 · Travel and Lodging: $636.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,475.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,725.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,677.11 |
| Food and Beverage | $3,502.13 |
| Travel and Lodging | $636.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $27,677.27 | 2019-2024 | Impella |
| Magenta Medical INC | $13,638.34 | 2023-2025 | |
| Cardiovascular Systems INC. | $10,455.54 | 2019-2023 | |
| Biotronik INC. | $5,035.28 | 2025 | Pk Papyrus, Orsiro Mission |
| Medtronic, INC. | $3,859.94 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Onyx Frontier |
| Spectrawave, INC | $3,016.72 | 2025 | Starlight Imaging Catheter, Hypervue Imaging System, X1-Ffr |
| Cathworks, INC. | $2,632.69 | 2022-2025 | Ffrangio |
| Medtronic Vascular, INC. | $1,691.42 | 2019-2020 | |
| Boston Scientific Corporation | $1,379.25 | 2019-2025 | General - Balloon Catheters |
| Zoll Circulation INC | $1,136.31 | 2021-2025 | Downstream Cartridge, Catheter, Therox Ds2 Console |
| Celonova Biosciences, INC. | $800.00 | 2020 | |
| Abbott Laboratories | $540.33 | 2019-2024 | Optis, Amplatzer Amulet, Diamondback Coronary |
| Shockwave Medical, INC | $479.45 | 2025 | |
| Philips North America LLC | $379.44 | 2019-2020 | |
| Teleflex LLC | $236.47 | 2023-2025 | Manta, Orsiro Mission, Guideliner |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $149.11 | 2020 | |
| Livanova USA, INC. | $133.44 | 2023 | Lifesparc |
| Alnylam Pharmaceuticals INC. | $122.83 | 2023 | Amvuttra |
| Amgen INC. | $112.98 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $110.60 | 2025 | Lifevest |
| Edwards Lifesciences Corporation | $107.15 | 2019 | |
| Penumbra, INC. | $103.26 | 2020 | |
| Angiodynamics, INC. | $36.71 | 2025 | Alphavac |
| Heartflow, INC. | $27.85 | 2020 | |
| Cardiva Medical, INC. | $24.69 | 2025 | Cardiva Vascade 5f Vcs |
| W. L. Gore & Associates, INC. | $24.64 | 2025 | Gore Cardioform Septal Occluder |
| Siemens Medical Solutions USA, INC. | $15.48 | 2023 | Artis Icono Floor |
| Pinnacle Biologics, INC | $13.67 | 2025 | Photofrin |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Perwaiz Meraj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.